Bioceres Reports 40% H1 Gross Margin, $179M Impairment on Pro Farm
Bioceres generated a consolidated gross margin of 40% for the six months ended December 2025 while facing Argentine farmer credit pressure and commodity weakness. The company recorded a $179 million impairment loss after a $15 million foreclosure auction on Pro Farm assets and flagged substantial going-concern doubt.
1. Q2 FY26 Financial Performance
Bioceres posted a consolidated gross margin of 40% year-to-date through December 31, 2025, despite Argentine farmer economics pressure from weak commodity prices and tighter credit conditions. The company maintained market share across crop protection, nutrition, and seed products while realigning cost structures to preserve margins.
2. Pro Farm Foreclosure and Impairment Loss
On January 20, 2026, noteholders acquired Pro Farm collateral assets for $15 million at auction, against a carrying value of $194 million, leading to a $179 million impairment under IFRS 5. Bioceres has classified these assets as discontinued operations and is pursuing legal remedies over the foreclosure terms.
3. Going Concern and Financing Strategies
Management disclosed substantial doubt about its ability to continue as a going concern, citing urgent needs for refinancing and capital structure improvements. The company is negotiating with Argentine banks, evaluating asset disposals, and noted the refinancing of Rizobacter Argentina’s Series VIII Class B bonds as a constructive step.
4. Governance Actions and Outlook
Bioceres strengthened its board with two non-executive directors to enhance oversight during the restructuring phase. The company plans to present a three-year financial plan focused on profitability and cash flow, underscoring confidence in its technology platform and improving Argentine macroeconomics.